Allergan Inc. and the St. Regis Mohawk Indian Tribe will petition the U.S. Supreme Court after a federal appeals court refused to reconsider its ruling that lets a challenge to Restasis patents proceed.
The U.S. Court of Appeals for the Federal Circuit Oct. 22 refused a full court rehearing on its decision allowing generic drugmakers Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., and Akorn Inc. to challenge the patents at the Patent and Trademark Office.
Michael W. Shore of Shore...
For more stories, analysis and expertiseOR Request Trial
(Updated with additional reporting throughout)